ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

All Content

In prostate cancer patients, a PSA nadir value of > 0.5 ng/mL after radiation therapy and androgen deprivation therapy can identify patients at a high risk of death.

This video examines an exploratory analysis of the RESORCE trial, which tested regorafenib vs placebo in hepatocellular carcinoma patients following radiographic progression on sorafenib.

A multicenter study showed that an occurrence of posttransplant skin cancer was common among a group of organ transplant recipients.

The PD-1 inhibitor pembrolizumab showed promising antitumor activity and acceptable safety in patients with advanced urothelial cancer, in a phase I trial.

Women with endometrioid ovarian cancer present at a younger age and with earlier stage disease than those with serous ovarian cancer, according to a new analysis. The earlier presentation resulted in better 5- and 10-year overall survival rates as well.

In this video we discuss efforts to reduce treatment doses in order to lessen long-term side effects and improve quality of life among patients with head and neck cancers.

The majority of hematologist-oncologists who use the social media platform Twitter had some financial conflict of interest, according to new data.

Certain patient-reported outcomes including fatigue and emotional support are associated with survival outcomes in patients with early-stage colorectal cancer.

Using a watch-and-wait strategy among a group of highly selected patients with rectal cancer who have undergone neoadjuvant chemoradiation did not appear to compromise outcomes.

A 43-year-old man presents with an anterior mediastinal mass. The mass is surgically resected and a biopsy is performed. What is your diagnosis?

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.